Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer

A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes

(2019) Naofumi Asano et al.   Nature Communications

Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer

(2019) Mahdieh Farzanehpour et al.   Virology Journal

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

(2019) Marc Arbyn et al.   Lancet Global Health

MicroRNAs as markers of progression in cervical cancer: a systematic review

(2018) Barbara Pardini et al.   BMC CANCER

MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7

(2017) Yongfeng Cao et al.   Oncology Letters

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients

(2012) M Schrevel et al.   BRITISH JOURNAL OF CANCER

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

(2012) S M Wilting et al.   ONCOGENE

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer

(2012) DONG-XIAN PENG et al.   ONCOLOGY REPORTS

Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection

(2012) Michael G. Schrauder et al.   PLoS One

Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix

(2012) Long Huang et al.   PLoS One

Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein

(2011) Bao Hua Li et al.   EUROPEAN JOURNAL OF CANCER

Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma

(2011) Kazuma Ohyashiki et al.   PLoS One

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

(2010) Nobuyoshi Kosaka et al.   CANCER SCIENCE

Polo-like kinase 1 (Plk1) in non-melanoma skin cancers

(2010) Travis Schmit et al.   CELL CYCLE

Targeting Polo-like Kinase in Cancer Therapy

(2010) Y. Degenhardt et al.   CLINICAL CANCER RESEARCH

Reduced miR-34a Expression in Normal Cervical Tissues and Cervical Lesions With High-Risk Human Papillomavirus Infection

(2010) Baohua Li et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid Carcinoma

(2009) T. C. Nappi et al.   CANCER RESEARCH

Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer

(2009) Wei Shi et al.   INTERNATIONAL JOURNAL OF CANCER

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and development

(2008) Tohru Takaki et al.   CURRENT OPINION IN CELL BIOLOGY

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY